TOKYO -- Fujifilm Holdings will soon apply to produce and sell its Avigan antiviral drug as a treatment for the new coronavirus in Japan, Nikkei learned Sunday.
The health ministry could give the go-ahead this year, making Avigan the third drug overall and the first domestically developed drug to receive such approval. Japan previously approved dexamethasone and remdesivir as coronavirus treatments.
